Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 5 |
| List of Tables | 4 | 2 |
| List of Figures | 6 | 1 |
| Sorrento Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 6 | 2 |
| Sorrento Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 8 | 1 |
| Sorrento Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 9 | 1 |
| Sorrento Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 10 | 1 |
| Sorrento Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 | 11 | 1 |
| Sorrento Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 12 | 3 |
| Sorrento Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details | 15 | 48 |
| Asset Purchase | 15 | 1 |
| Sorrento Therapeutics Acquires Rights to Cynviloq from Samyang Biopharma | 15 | 1 |
| Sorrento Therapeutics Acquires Rights To Cynviloq From Samyang Biopharma | 16 | 2 |
| Sorrento Therapeutics And IgDraSol Acquire Distribution Rights Of Cynviloq From Samyang Biopharma | 18 | 2 |
| Sorrento Therapeutics Acquires Rights To Produce Recombinant Intravenous Immunoglobulins | 20 | 1 |
| Partnerships | 21 | 1 |
| Sorrento Therapeutics and TNK Therapeutics Enters into Licensing Agreement with CytoLumina Technologies and FetoLumina Technologies | 21 | 1 |
| Sorrento Therapeutics to Form Joint Venture with CHA Biotech | 22 | 1 |
| TNK Therapeutics to Form Joint Venture with Shenyang Sunshine Pharma | 23 | 1 |
| Sorrento Therapeutics to Form Joint Venture with Yuhan | 24 | 1 |
| Sorrento Therapeutics Enters into Partnership with Karolinska Institutet | 25 | 1 |
| Sorrento Therapeutics and NantBioscience Form Joint Venture | 26 | 1 |
| Advaxis Enters into Research Agreement with Sorrento Therapeutics | 27 | 1 |
| Sorrento Therapeutics Enters into Co-Development Agreement with Conkwest | 28 | 1 |
| NantWorks to Form Joint Venture with Sorrento Therapeutics | 29 | 1 |
| Sorrento Therapeutics Enters into Co-Development Agreement with Morphotek | 30 | 1 |
| Sorrento Therapeutics Enters Into Co-Development Agreement With The Scripps Research Institute | 31 | 1 |
| Licensing Agreements | 32 | 1 |
| Les Laboratoires Servier Enters into Licensing Agreement with Sorrento Therapeutics | 32 | 2 |
| Sorrento Therapeutics Enters into Licensing Agreement with City of Hope | 34 | 1 |
| Sorrento Therapeutics Enters into Licensing Agreement with Mabtech | 35 | 1 |
| Sorrento Therapeutics Enters into Licensing Agreement with Globavir Biosciences | 36 | 1 |
| NantWorks to Enter into Licensing Agreement with Sorrento Therapeutics | 37 | 1 |
| Sorrento Therapeutics Enters into Licensing Agreement with Lee's Pharma for Anti-PD-L1 Antibody | 38 | 2 |
| Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute | 40 | 1 |
| Sorrento Therapeutics Enters Into Licensing Agreement With Lonza For GS Xceed Gene Expression System | 41 | 1 |
| Sorrento Therapeutics Enters Into Option For Licensing Agreement With B.G. Negev Technologies and Applications For HCV Antibody Clones | 42 | 1 |
| Equity Offering | 43 | 1 |
| Sorrento Therapeutics Raises USD140 Million in Private Placement of Shares and Warrants | 43 | 2 |
| Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants | 45 | 2 |
| Sorrento Therapeutics Announces Underwriters Exercise of Over-Allotment Option of Public Offering of Shares | 47 | 2 |
| Sorrento Therapeutics Completes Public Offering Of Shares For US$34.6 Million | 49 | 2 |
| Sorrento Therapeutics Files Registration Statement For Public Offering Of Securities For Up To US$100 Million | 51 | 1 |
| Sorrento Therapeutics Completes Private Placement Of Shares For US$2 Million | 52 | 1 |
| Acquisition | 53 | 1 |
| Scintilla Pharma to Acquire Semnur Pharma | 53 | 1 |
| Scintilla Pharma to Acquire Scilex Pharma for Up to USD70 Million | 54 | 2 |
| TNK Therapeutics Acquires Two Biotechnology Companies | 56 | 1 |
| NantPharma Acquires IgDraSol from Sorrento Therapeutics | 57 | 1 |
| NantWorks to Acquire 19.9% Stake in Sorrento Therapeutics for USD41.7 Million | 58 | 1 |
| Sorrento Therapeutics Completes Acquisition Of Concortis Biosystems For Up To US$12 Million | 59 | 1 |
| Sorrento Acquires Sherrington, Chronic Pain Therapies Provider | 60 | 1 |
| Sorrento Therapeutics Completes Acquisition Of IgDraSol For US$28.2 Million | 61 | 2 |
| Sorrento Therapeutics, Inc. - Key Competitors | 63 | 1 |
| Key Employees | 64 | 1 |
| Locations And Subsidiaries | 65 | 1 |
| Head Office | 65 | 1 |
| Other Locations &Subsidiaries | 65 | 1 |
| Appendix | 66 | 1 |
| Methodology | 66 | 1 |
| About GlobalData | 66 | 1 |
| Contact Us | 66 | 1 |
| Disclaimer | 66 | 1 |